Read the latest edition of Person-centred Care Insights. Discover a rich array of resources empowering person-centred care: our robust Resource Hub, innovative initiatives, new support materials, ongoing research projects, and the latest expert publications.
Have your say on the In-house in Vitro Diagnostic Medical Devices and Point of Care Testing Standards.
Have your say on the In-house in Vitro Diagnostic Medical Devices and Point of Care Testing Standards.
The Australian Group on Antimicrobial Resistance (AGAR) annually publishes data on antimicrobial resistance (AMR) and epidemiologic and genetic patterns in bloodstream infections in Australia, relating to three main organisms: enterococcal species, Staphylococcus aureus and gram-negative bacteria.
Released December 2023
A public consultation on the Module was conducted between October 2022 and February 2023. This document outlines the public consultation process and summarises participation and the feedback received.
Findings from the consultation process were used to inform amendments to the Module and will support the development of implementation resources.
On the Radar Issue 633 is now available.
Today the Australian Commission on Safety and Quality in Health Care released the National Safety and Quality Cosmetic Surgery Standards as part of broader reforms agreed by Health Ministers.
Today the Australian Commission on Safety and Quality in Health Care released the National Safety and Quality Cosmetic Surgery Standards as part of broader reforms agreed by Health Ministers.
This fact sheet explains some actions for consumers and/or their carers take to help keep safe while using insulin. Insulins are available in different strengths and formulations or presentations with medicine names that look and sound similar. Consumers need to ‘stop, think and check’ that they have the right brand of insulin in the right strength before administering.
This factsheet highlights best practise dispensing to support safe and quality use of insulin, within the context of active ingredient prescribing. Safe and quality use of insulins requires clear information transfer from initial prescribing to the dispensing label, to ensure safe use by consumers and/or their carers.